These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16794009)

  • 21. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
    Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
    J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TNF family member APRIL dampens collagen-induced arthritis.
    Fernandez L; Salinas GF; Rocha C; Carvalho-Pinto CE; Yeremenko N; Papon L; Medema JP; Combe B; Morel J; Baeten D; Hahne M
    Ann Rheum Dis; 2013 Aug; 72(8):1367-74. PubMed ID: 23178293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
    Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TACI and BAFF-R mediate isotype switching in B cells.
    Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
    J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
    Xu S; Lam KP
    Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAFF costimulation of Toll-like receptor-activated B-1 cells.
    Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
    Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.
    Avery DT; Kalled SL; Ellyard JI; Ambrose C; Bixler SA; Thien M; Brink R; Mackay F; Hodgkin PD; Tangye SG
    J Clin Invest; 2003 Jul; 112(2):286-97. PubMed ID: 12865416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells.
    Yang M; Hase H; Legarda-Addison D; Varughese L; Seed B; Ting AT
    J Immunol; 2005 Sep; 175(5):2814-24. PubMed ID: 16116167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
    Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAFF: a fundamental survival factor for B cells.
    Mackay F; Browning JL
    Nat Rev Immunol; 2002 Jul; 2(7):465-75. PubMed ID: 12094221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
    J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.
    Schiemann B; Gommerman JL; Vora K; Cachero TG; Shulga-Morskaya S; Dobles M; Frew E; Scott ML
    Science; 2001 Sep; 293(5537):2111-4. PubMed ID: 11509691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
    Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
    Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of BAFF in autoimmune diseases].
    Matsushita T; Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):333-42. PubMed ID: 16276047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution.
    Guan ZB; Shui Y; Zhang SQ
    Cytokine; 2007 Sep; 39(3):192-200. PubMed ID: 17822916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
    Thompson JS; Bixler SA; Qian F; Vora K; Scott ML; Cachero TG; Hession C; Schneider P; Sizing ID; Mullen C; Strauch K; Zafari M; Benjamin CD; Tschopp J; Browning JL; Ambrose C
    Science; 2001 Sep; 293(5537):2108-11. PubMed ID: 11509692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
    Saitoh O; Nagayama Y
    Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
    Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
    Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.